RUNX3 Epigenetic Inactivation Is Associated With Estrogen Receptor Positive Breast Cancer
Authors:
- 22 August 2018
- journal article
- research article
- Published by SAGE Publications in Journal of Histochemistry & Cytochemistry
- Vol. 66 (10) , 709-721
Abstract
The role of Runt-related transcription factor 3 ( RUNX3) gene in breast cancer remains not fully understood. We studied the correlation between RUNX3 gene promoter methylation and estrogen receptor (ER) expression status in breast cancer. Three breast cancer cell lines and 113 formalin-fixed, paraffin-embedded breast cancer tissue samples were analyzed for RUNX3 expression. Methylation-specific polymerase chain reaction was used to analyze RUNX3 methylation on the samples. Migration and invasion ability were evaluated in MCF7 cell line (RUNX3 methylated) treated with methylation inhibitor 5-Aza-2′-deoxycytidine (5-Aza-CdR) to study the effect of RUNX3 methylation status. Our data showed that the expression of RUNX3 was high in MCF10A but not in MCF7 and SKBR3 cell lines, while the RUNX3 promoter showed hypermethylation in MCF7 but not in MCF10A and SKBR3. In tissues samples, Immunohistochemical (IHC) expression of RUNX3 protein was higher in ER-negative samples than in ER-positive cases, and it was negatively correlated with the methylation status of the RUNX3 gene promoter. Proliferation, migration, and invasion of MCF7 were suppressed when 5-Aza-CdR treated. Also, the hypermethylation status of RUNX3 gene promoter was reversed and RUNX3 expression was increased. In summary, our data suggest that hypermethylation of the RUNX3 gene promoter may play an important role in ER-positive breast tumor progression.Keywords
Funding Information
- Xuzhou Science and Technology Project (KC15SH043)
- Special Foundation of President of Xuzhou Medical University (09KJZ05)
This publication has 22 references indexed in Scilit:
- The clinicopathological significance of RUNX3 hypermethylation and mRNA expression in human breast cancer, a meta-analysisOncoTargets and Therapy, 2016
- Cancer epigenetics and targeted therapies.2011
- Expression of RUNX3 Gene, Methylation Status and Clinicopathological Significance in Breast Cancer and Breast Cancer Cell LinesPathobiology, 2008
- The Quest for the1p36Tumor SuppressorCancer Research, 2008
- Targets of genome copy number reduction in primary breast cancers identified by integrative genomicsGenes, Chromosomes and Cancer, 2006
- Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemiaBlood, 2006
- DNA Methylation Changes after 5-Aza-2′-Deoxycytidine Therapy in Patients with LeukemiaCancer Research, 2006
- DNA methylation-associated inactivation of TGFβ-related genes DRM/Gremlin, RUNX3, and HPP1 in human cancersBritish Journal of Cancer, 2005
- Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinomaLaboratory Investigation, 2004
- The Role of DNA Methylation in Mammalian EpigeneticsScience, 2001